Results with an anticoagulation protocol in 99 syncardia total artificial heart recipients

Jack Copeland, Hannah Copeland, Paul Nolan, Monica Gustafson, Marvin J Slepian, Richard Smith

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

For 15 years, we employed a consistent anticoagulation protocol in 99 consecutive SynCardia Systems total artificial heart (TAH) recipients. Thromboelastography and platelet aggregation studies were used for evaluating and modulating therapy with dipyridamole, pentoxiphylline, aspirin, and heparin. Partial thromboplastin times, international normalized ratios, and platelet counts were also followed. After the second post-implant day in patients who were free of endo-device infection (97 patients), the embolic stroke incidence was 0.08 per patient year. This included 23.6 patient years of device support. There were no spontaneous hemorrhagic strokes. Two patients had endo-device infections and both had strokes. Postimplantation bleeding was seen in 20% of patients. All but two of these were within the first postoperative week. In all, 4% of patients had gastrointestinal bleeding. We did not observe heparin-induced thrombocytopenia in any patient. We conclude that stroke rates on TAH support have been low, and recommend this protocol.

Original languageEnglish (US)
Pages (from-to)216-220
Number of pages5
JournalASAIO Journal
Volume59
Issue number3
DOIs
StatePublished - May 2013

Fingerprint

Artificial heart
Artificial Heart
Platelets
Heparin
Dipyridamole
Thromboplastin
Aspirin
Agglomeration
Stroke
Equipment and Supplies
Hemorrhage
Thrombelastography
International Normalized Ratio
Partial Thromboplastin Time
Infection
Platelet Count
Platelet Aggregation
Thrombocytopenia
Incidence

Keywords

  • anticoagulation protocol
  • clinical outcomes
  • total artificial heart

ASJC Scopus subject areas

  • Biophysics
  • Biomaterials
  • Bioengineering
  • Biomedical Engineering
  • Medicine(all)

Cite this

Results with an anticoagulation protocol in 99 syncardia total artificial heart recipients. / Copeland, Jack; Copeland, Hannah; Nolan, Paul; Gustafson, Monica; Slepian, Marvin J; Smith, Richard.

In: ASAIO Journal, Vol. 59, No. 3, 05.2013, p. 216-220.

Research output: Contribution to journalArticle

Copeland, Jack ; Copeland, Hannah ; Nolan, Paul ; Gustafson, Monica ; Slepian, Marvin J ; Smith, Richard. / Results with an anticoagulation protocol in 99 syncardia total artificial heart recipients. In: ASAIO Journal. 2013 ; Vol. 59, No. 3. pp. 216-220.
@article{1e160bc802044a6ba99a072d93df9d86,
title = "Results with an anticoagulation protocol in 99 syncardia total artificial heart recipients",
abstract = "For 15 years, we employed a consistent anticoagulation protocol in 99 consecutive SynCardia Systems total artificial heart (TAH) recipients. Thromboelastography and platelet aggregation studies were used for evaluating and modulating therapy with dipyridamole, pentoxiphylline, aspirin, and heparin. Partial thromboplastin times, international normalized ratios, and platelet counts were also followed. After the second post-implant day in patients who were free of endo-device infection (97 patients), the embolic stroke incidence was 0.08 per patient year. This included 23.6 patient years of device support. There were no spontaneous hemorrhagic strokes. Two patients had endo-device infections and both had strokes. Postimplantation bleeding was seen in 20{\%} of patients. All but two of these were within the first postoperative week. In all, 4{\%} of patients had gastrointestinal bleeding. We did not observe heparin-induced thrombocytopenia in any patient. We conclude that stroke rates on TAH support have been low, and recommend this protocol.",
keywords = "anticoagulation protocol, clinical outcomes, total artificial heart",
author = "Jack Copeland and Hannah Copeland and Paul Nolan and Monica Gustafson and Slepian, {Marvin J} and Richard Smith",
year = "2013",
month = "5",
doi = "10.1097/MAT.0b013e318288a390",
language = "English (US)",
volume = "59",
pages = "216--220",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Results with an anticoagulation protocol in 99 syncardia total artificial heart recipients

AU - Copeland, Jack

AU - Copeland, Hannah

AU - Nolan, Paul

AU - Gustafson, Monica

AU - Slepian, Marvin J

AU - Smith, Richard

PY - 2013/5

Y1 - 2013/5

N2 - For 15 years, we employed a consistent anticoagulation protocol in 99 consecutive SynCardia Systems total artificial heart (TAH) recipients. Thromboelastography and platelet aggregation studies were used for evaluating and modulating therapy with dipyridamole, pentoxiphylline, aspirin, and heparin. Partial thromboplastin times, international normalized ratios, and platelet counts were also followed. After the second post-implant day in patients who were free of endo-device infection (97 patients), the embolic stroke incidence was 0.08 per patient year. This included 23.6 patient years of device support. There were no spontaneous hemorrhagic strokes. Two patients had endo-device infections and both had strokes. Postimplantation bleeding was seen in 20% of patients. All but two of these were within the first postoperative week. In all, 4% of patients had gastrointestinal bleeding. We did not observe heparin-induced thrombocytopenia in any patient. We conclude that stroke rates on TAH support have been low, and recommend this protocol.

AB - For 15 years, we employed a consistent anticoagulation protocol in 99 consecutive SynCardia Systems total artificial heart (TAH) recipients. Thromboelastography and platelet aggregation studies were used for evaluating and modulating therapy with dipyridamole, pentoxiphylline, aspirin, and heparin. Partial thromboplastin times, international normalized ratios, and platelet counts were also followed. After the second post-implant day in patients who were free of endo-device infection (97 patients), the embolic stroke incidence was 0.08 per patient year. This included 23.6 patient years of device support. There were no spontaneous hemorrhagic strokes. Two patients had endo-device infections and both had strokes. Postimplantation bleeding was seen in 20% of patients. All but two of these were within the first postoperative week. In all, 4% of patients had gastrointestinal bleeding. We did not observe heparin-induced thrombocytopenia in any patient. We conclude that stroke rates on TAH support have been low, and recommend this protocol.

KW - anticoagulation protocol

KW - clinical outcomes

KW - total artificial heart

UR - http://www.scopus.com/inward/record.url?scp=84877737929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877737929&partnerID=8YFLogxK

U2 - 10.1097/MAT.0b013e318288a390

DO - 10.1097/MAT.0b013e318288a390

M3 - Article

C2 - 23644607

AN - SCOPUS:84877737929

VL - 59

SP - 216

EP - 220

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 3

ER -